As an example, according to the American Society of Clinical Oncology (ASCO) [56] and European Society for Medical Oncology (ESMO) [57] guidelines, the analysis of the hormonal receptor characteristics constitutes a standard in BC and PC in order to apply therapy decisions. Here, NR4A1 is linked to breast cancer.